Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Sales | 1,887 | 1,904 | 1,701 | 1,970 | 2,319 |
| Gross Profit | 1,887 | 1,904 | 1,701 | 1,970 | 2,319 |
| Operating Expenses | 11,723 | 9,350 | 9,698 | 8,298 | 9,636 |
| Operating Income | -9,836 | -7,446 | -7,997 | -6,328 | -7,317 |
| Interest Expense | 0 | 0 | 3 | 0 | -3 |
| Other Income | 118 | 124 | 158 | 224 | 299 |
| Pre-tax Income | -9,718 | -7,322 | -7,842 | -6,104 | -7,016 |
| Net Income Continuous | -9,718 | -7,322 | -7,842 | -6,104 | -7,016 |
| Net Income | $-9,718 | $-7,322 | $-7,842 | $-6,104 | $-7,016 |
| EPS Basic Total Ops | -0.67 | -0.56 | -0.61 | -0.48 | -0.56 |
| EPS Basic Continuous Ops | -0.67 | -0.56 | -0.61 | -0.48 | -0.56 |
| EPS Diluted Total Ops | -0.67 | -0.56 | -0.61 | -0.48 | -0.56 |
| EPS Diluted Continuous Ops | -0.67 | -0.56 | -0.61 | -0.48 | -0.56 |
| EBITDA(a) | $-9,390 | $-6,980 | $-7,540 | $-5,780 | $-6,686 |